產品資訊 - API->pharmaceutical

登入

加入會員

求助

Nanjing Limu Pharmaceutical Co., Ltd

	Recommended Results

API

產品分類 :

化學->藥品->醫藥

產品規格

Country	CN
Packing	25kg/drum
Payment Term	L/C T/T

產品描述

Nanjing Limu pharmaceutical Co.,Ltd is one of the largest leading suppliers of Oxytetracycline base, Oxytetracycline hyclate, Doxycycline hyclate, Streptomycin sulphate , Colistin Sulfate, Tylosin tartrate , Mequindox, Enrofloxacin Hydrochloride, Metamizole sodium, Levamisole HCL, Florfenicol, Toltrazuril, Dextrose anhydrous
Dextrose Monohydrate, etc. Limu is a high technology Pharmaceutical company, which is engaged both in producing fine chemical, pharmaceutical excipients & veterinary medicine and distributing the products of our own company and affiliated enterprises.
The company invests large fund and brains to R&D department to research fine chemical, pharmaceutical excipients & veterinary medicine that fit the demand of the market. High level research group, advanced apparatus and good scientific atmosphere ensure the quality of R&D. All the products in plant are the fruit of R&D department. Our products reach the advanced standard of domestic market, some of which reach the international standard. We have the authority of export and import, pharmaceutical & its intermediates distributed by the company are sold both in the domestic and international market and highly recommended by our clients. Resorting to the strong cooperation relationships with big-scale breeding enterprises; more than one thousand wholesalers in China and exporting to many other countries and regions, we have rapidly grown into one of the best pharmaceutical excipients and veterinary medicine suppliers in China.
We hold the management creed "Based talent, Science leads, Limu service, Credit forever" firmly, we also insist on the quality tenet "Improving quality for survival, Satisfying the customs; Gaining benefit from service, Achieving the credit through self-discipline".
The strategy of the Group is to build a leading speciality pharmaceutical company through the acquisition, integration and development of late-stage pharmaceuticals and medical devices. We sincerely hope to make cooperation with all of the supplier and customers, and share the good credit standing and respectability.